Atrophic Vaginitis in the Menopause

摘要: Vulvovaginal atrophy and atrophic vaginitis are extremely common variants of lower genital tract states estrogen deficiency affecting women all socioepidemiologic strata worldwide. Recent molecular studies have emerged linking vaginal microbiota to vulvovaginal atrophy. Unfortunately these clinical conditions under-recognized, underappreciated, untreated, resulting in unnecessary suffering. Clinical manifestations highly variable described here together with differential diagnosis, laboratory treatment modalities. Multiple therapeutic options now available although regrettably often unaffordable. Treatments local systemic adverse effects complications particular reference symptomatic postmenopausal receptor-positive breast cancer. Additional safer, inexpensive regimens needed.